Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: More likely than not
The settlement with Barco is most likely a way to show the Judge TPL has merit, inceases the cash resources to further battle the remaining participants, and simplifies the case for TPL. I highly doubt the Barco settlement is any different than the J3 early settlements. No dividends or public $s is crystal clear in my mind that this settlemeny is no where close to the settlements we need to get to the prices we all want. The truth hurts ...
Share
New Message
Please login to post a reply